Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
10/2005
10/20/2005CA2561945A1 Non-imidazole heterocyclic compounds as histamine h3 receptor modulators
10/20/2005CA2560162A1 Inhibitors of iap
10/19/2005EP1586564A1 8-azaprostaglandin derivatives and medicinal uses thereof
10/19/2005EP1586561A1 Bicyclic aromatic sulfinyl derivatives
10/19/2005EP1586559A1 Biaryl-methanethio-, -sulphinyl- and sulphonyl derivatives
10/19/2005EP1586553A1 Process for preparing amines
10/19/2005EP1586322A2 Compositions for inhibition of anglogenesis
10/19/2005EP1585745A1 Fc receptor modulating compounds and compositions
10/19/2005EP1585515A2 Piperidine and pyrrolidine derivatives as antagonists of histamine h3 receptor
10/19/2005EP1322597A4 Process and intermediates
10/19/2005EP1137635B1 N-substituted 2-cyanopyrrolidines
10/19/2005CN1684945A Process for preparing intermediates
10/19/2005CN1684944A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/19/2005CN1683336A Process for synthesizing acyl imidogen substituted cyclo compound
10/19/2005CN1683335A Process for preparing (S)-1-allyl-2-amidomethyl tetrahydropyrrole
10/19/2005CN1223584C Pyrrolecarboxamides for use as fungicides
10/18/2005US6956037 Benzamide derivatives for the treatment of diseases mediated by cytokines
10/18/2005US6955921 Trypsin substrate and diagnostic device, and method of using same
10/18/2005US6955888 Methods of screening agents, conjugates or conjugate moieties for transport by a PEPT2 transporter
10/18/2005CA2339273C Branched alkyl pyrrolidine-3-carboxylic acids
10/18/2005CA2307581C Heterocyclic compounds having nos inhibiting action
10/18/2005CA2294171C N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
10/18/2005CA2240728C Kappa agonist compounds and pharmaceutical formulations thereof
10/18/2005CA2156288C Glycerol derivative, device and pharmaceutical composition
10/13/2005WO2005095351A1 N1 - ((pyrazol-1-ymethyl) -2-methylphenyl)- phatalamide derivatives and related compounds insecticides
10/13/2005WO2005095343A1 Dpp-iv inhibitors
10/13/2005WO2005095340A1 Process for preparing n-protected 4-ketoproline derivatives
10/13/2005WO2005095339A1 Dicyanopyrrolidines as dipeptidyl peptidase iv inhibitors
10/13/2005WO2005095338A1 Alkoxyphenylpropanoic acid derivatives
10/13/2005WO2005095327A1 Aniline derivatives
10/13/2005WO2005094897A2 Pegylated ion channel modulating compounds
10/13/2005WO2005066122A3 Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
10/13/2005WO2005021536A3 Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors
10/13/2005WO2004113277A3 Methods and compositions for treating amyloid-related diseases
10/13/2005US20050228187 Process for the preparation of activated polyethylene glycols
10/13/2005US20050228186 Simple stereocontrolled synthesis of salinosporamide A
10/13/2005US20050228040 Bicyclic aromatic sulfinyl derivatives
10/13/2005US20050228021 Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods
10/13/2005US20050227995 Phenyl sulfoxides and phenyl sulfones
10/13/2005US20050227982 Antileishmanial dinitroaniline sulfanomides with activity against parasite tubulin
10/13/2005US20050227979 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety
10/13/2005US20050227978 Fibrosis inhibitor
10/13/2005US20050227973 Human adam-10 inhibitors
10/13/2005US20050227948 Hif hydroxylase inhibitors
10/13/2005US20050227076 used for immobilization of amine-containing materials such as amino acid, peptide, protein, enzyme, immunoglobulin, DNA, RNA or fragments to substrate surfaces
10/13/2005US20050227021 To produce anisotropic polymers for use in optical and electrooptical devices, adhesives, synthetic resins with anisotropic mechanical properties, cosmetics, diagnostics, liquid crystal pigments, decorative and security applications, nonlinear optics, optical information storage, electronic devices
10/13/2005DE10392134T5 Azaphenylalaninderivate Azaphenylalaninderivate
10/13/2005DE102004014945A1 Prolinylderivate Prolinylderivate
10/13/2005CA2561733A1 Pegylated ion channel modulating compounds
10/13/2005CA2558446A1 Dpp-iv inhibitors
10/12/2005EP1584616A1 Industrial process for the production of crystalline atorvastatin trihydrate hemi calcium salt
10/12/2005EP1583972A2 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
10/12/2005EP1583745A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
10/12/2005EP1583742A1 Novel cb 1 receptour inverse agonists
10/12/2005EP1583741A1 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists
10/12/2005EP1583726A2 Activity-based probes, and methods of their preparation and use
10/12/2005CN1681780A Biological low-molecular weight derivatives
10/12/2005CN1681779A 4-pyrrolidino-phenyl-benzyl ether derivatives
10/12/2005CN1681778A Pyrrolidone derivatives as MAOB inhibitors
10/12/2005CN1681777A Pyrrolidone derivatives as MAOB inhibitors
10/12/2005CN1681771A 4-(3, 3-dihalo-allyloxy)phenoxy alkyl derivatives
10/12/2005CN1681500A Topical treatment of skin diseases
10/12/2005CN1681490A Melanin extinguisher
10/12/2005CN1680338A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2005CN1680316A Preparation of imide unsaturated ketone
10/12/2005CN1680315A Process for the production of amorphous atorvastatin calcium
10/12/2005CN1680314A 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
10/12/2005CN1680313A Farnesyl transferase inhibitors
10/12/2005CN1680272A C2-phenyl-substituted cyclic keto-enols used as pesticides and herbicides
10/12/2005CN1222521C Proces for synthesis of 5-(4-fluorophenyl)-1-[2R, 4R]-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxypic acid phenylamide
10/12/2005CN1222519C Reverse hydroxamate inhibitors of matrix metalloproteinases
10/12/2005CN1222510C Novel benzoylguanidine salt
10/12/2005CN1222508C Process for preparation of condensed sulfamide
10/11/2005US6953858 A phenylalkyl secondary- and tertiary-amides enzyme inhibitors as viricides, for treating AIDS
10/11/2005US6953806 Cyclohexane derivatives containing amine or amine oxide, useful for treating hypercholesterolemia and hyperlipemia
10/11/2005US6953798 compounds are able to inhibit binding of alpha 4 integrins to their ligands and are of use in prophylaxis and treatment of immune or inflammatory disorders
10/11/2005US6953792 Cyclohexyl derivatives and their use as therapeutic agents
10/11/2005US6953789 a 3- or 4-Mercapto-1-(4-phenoxybenzyl)azepine-2-one; thioetherification with a mercaptan; matrix metalloprotease (MMP) inhibitors; antiarthritic, anticaries agent;
10/11/2005US6953606 For use as solvents e.g., in cleaning procedures such as dry cleaning, water removal and in coating; replacements for chlorinated chemicals , low global warming potentials
10/06/2005WO2005092897A2 2,4,6-phenylsubstituted cyclic ketoenoles
10/06/2005WO2005092881A1 Novel pyrrolidine-3,4-dicarboxamide derivatives
10/06/2005WO2005092852A1 Process for the production of atorvastatin calcium in amorphous form
10/06/2005WO2005092851A1 Method for purifying n-methyl-2-pyrrolidone
10/06/2005WO2005092850A1 Amino acid and peptide conjugates of arylalkylic acids for cosmetic use
10/06/2005WO2005092849A1 Prolinyl derivatives for treating thrombosis
10/06/2005WO2005092320A1 Cytoprotective composition
10/06/2005WO2005075978A3 Time-temperature indicator based on valence isomerizations
10/06/2005WO2005075420A3 Pyrrolidine derivatives acting as ccr3-receptor antagonists
10/06/2005WO2005073216A3 Hcv ns-3 serine protease inhibitors
10/06/2005WO2005066135A3 Pyrrole and pyrazole daao inhibitors
10/06/2005WO2005046599A3 Alpha, beta-unsaturated sulfoxides for treating proliferative disorders
10/06/2005US20050222432 Reacting a pyrrole with chlorosulfonyl isocyanate in the presence of a solvent and contacting the resulting product with a molar excess of an amide such as N,N-dimethylformamide
10/06/2005US20050222431 Formation of a thiocarbamate from a haloformic compound, dehalo-esterification, coupling an N-hydroxysuccinimide or secondary amide-containing drug; prodrugs of gabapentin and baclofen; improved bioavailability
10/06/2005US20050222430 Decarboxylating an alpha -amino acid under heating in a high boiling liquid polymer having average molecular weight 200 to 6000, and directly recovering said amine by distillation
10/06/2005US20050222414 N-(4-methylphenyl)-4-[4-[[(phenylmethoxy)amino]carbonyl]phenyl]-1-piperazinecarboxamide; anticarcinogenic, antiproliferative agent; ovarian carcinoma, psoriasis; gene transcription control
10/06/2005US20050222395 New peptide derivatives
10/06/2005US20050222222 1-[3-[2-[2-cyano-(S)-pyrrolidin-1-yl]-2-oxo-ethylamino]-1-oxo-propyl]-4-[bis-(4-fluorophenyl)methyl]piperazine; inhibiting dipeptidyl peptidase IV or for treating Type II diabetes
10/06/2005US20050222200 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist
10/06/2005US20050222146 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
10/06/2005US20050222140 Improved DP-IV inhibitors increase the steady state concentrations of GLP-1 and GIP, resulting in improved glucose tolerance
1 ... 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 ... 404